We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Compass Minerals
CMP
$1.23B
| $4.49M | 0.01% |
53,264
+5,287
| +11% | +$474K |
|
827
Charles River Laboratories
CRL
$11.2B
| $4.49M | 0.01% |
75,070
+977
| +1% | +$55.9K |
|
828
Valmont Industries
VMI
$9.3B
| $4.49M | 0.01% |
33,240
+992
| +3% | +$142K |
|
829
Archrock
AROC
$6.27B
| $4.47M | 0.01% |
100,938
+2,089
| +2% | +$91.8K |
|
830
John Wiley & Sons Class A
WLY
$2.65B
| $4.46M | 0.01% |
79,557
-10,821
| -12% | -$644K |
|
831
Ionis Pharmaceuticals
IONS
$8.6B
| $4.46M | 0.01% |
114,948
-1,925
| -2% | -$68.2K |
|
832
Darling Ingredients
DAR
$9.64B
| $4.45M | 0.01% |
243,120
+950
| +0.4% | +$18.4K |
|
833
Cheesecake Factory
CAKE
$5.04B
| $4.44M | 0.01% |
97,675
+13,010
| +15% | +$583K |
|
834
Amdocs
DOX
$5.92B
| $4.43M | 0.01% |
96,605
-54,277
| -36% | -$2.54M |
|
|
BYI
835
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
| $4.42M | 0.01% |
54,815
-263
| -0.5% | -$19.2K |
|
836
Cracker Barrel
CBRL
$1.26B
| $4.42M | 0.01% |
42,862
-11,975
| -22% | -$1.2M |
|
|
CYN
837
DELISTED
CITY NATIONAL CORPORATION
CYN
| $4.42M | 0.01% |
58,387
-1,158
| -2% | -$87.5K |
|
|
VVC
838
DELISTED
Vectren Corporation
VVC
| $4.4M | 0.01% |
110,345
+1,800
| +2% | +$72.2K |
|
|
GXP
839
DELISTED
Great Plains Energy Incorporated
GXP
| $4.38M | 0.01% |
181,124
-750
| -0.4% | -$19K |
|
840
Enovis
ENOV
$1.68B
| $4.36M | 0.01% |
44,443
+4
| +0% | +$449 |
|
|
WGL
841
DELISTED
Wgl Holdings
WGL
| $4.35M | 0.01% |
103,184
+520
| +0.5% | +$21.8K |
|
842
Timken Company
TKR
$9.56B
| $4.34M | 0.01% |
102,504
-40,135
| -28% | -$1.85M |
|
843
Erie Indemnity
ERIE
$12.7B
| $4.33M | 0.01% |
57,183
+8,963
| +19% | +$675K |
|
|
ISBC
844
DELISTED
Investors Bancorp, Inc.
ISBC
| $4.33M | 0.01% |
427,682
+2,700
| +0.6% | +$28.5K |
|
|
WBC
845
DELISTED
WABCO HOLDINGS INC.
WBC
| $4.33M | 0.01% |
47,552
-887
| -2% | -$89.5K |
|
846
Old Republic International
ORI
$10.5B
| $4.29M | 0.01% |
300,740
-25,000
| -8% | -$382K |
|
|
CPWR
847
DELISTED
COMPUWARE CORP
CPWR
| $4.29M | 0.01% |
420,545
+1,041
| +0.2% | +$9.79K |
|
848
Oil States International
OIS
$489M
| $4.28M | 0.01% |
69,151
+924
| +1% | +$58K |
|
|
XLS
849
DELISTED
EXELIS INC COM STK
XLS
| $4.28M | 0.01% |
258,764
-17,987
| -6% | -$292K |
|
|
TGI
850
DELISTED
Triumph Group
TGI
| $4.26M | 0.01% |
65,467
-490
| -0.7% | -$32.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.